Acronym eOnco Title Wirelessly activated multifunctional nanobioelectronics to enable novel oncological therapies Summary

Membrane potential of cancer cells possess more depolarised values than healthy cells that heighten proliferation and invasion states. eOnco’s aim is to develop wireless nanobioelectronic systems based on electrically-responsive MNPs. These can be stimulated and polarised remotely using non-invasive methods (NIR and/or US) in order to transmit an electrical cue to cancer cells. MNPs’ activation will increase polarisation of cancer cells membrane to halt cell proliferation that ultimately leads to cancer cell death.

 

Project webpage Start year 01/03/2023 End year 28/02/2025 ID 2022.07252.PTDC iBB Role Coordinator iBB Budget € 49 994,62 Research Group SCERG PI Paola Alberte Project Partners n.a. Status Ongoing Funding FCT